Pharmerica Competitors

Pharmerica (CNSX:PMC) and (ASE) (CNSX:ASE) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Pharmerica and (ASE)'s net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Pharmerica and (ASE)'s gross revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and (ASE), as provided by MarketBeat.com.

Pharmerica (CNSX:PMC) and (GOLD.V) (CVE:GOLD) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Pharmerica and (GOLD.V)'s net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Pharmerica and (GOLD.V)'s gross revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and (GOLD.V), as provided by MarketBeat.com.

(GOLD.V) has a consensus price target of C$7.50, suggesting a potential upside of 733.33%.

Pharmerica (CNSX:PMC) and (RLG) (CNSX:RLG) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Pharmerica and (RLG)'s net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Pharmerica and (RLG)'s gross revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and (RLG), as provided by MarketBeat.com.

Pharmerica (CNSX:PMC) and 3737 (CNSX:RFR) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Pharmerica and 3737's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Pharmerica and 3737's gross revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and 3737, as provided by MarketBeat.com.

3737 has a consensus price target of $0.12, suggesting a potential upside of ∞.

Summary

3737 beats Pharmerica on 1 of the 1 factors compared between the two stocks.

Pharmerica (CNSX:PMC) and American CuMo Mining (CVE:MLY) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Profitability

This table compares Pharmerica and American CuMo Mining's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Pharmerica and American CuMo Mining's gross revenue, earnings per share (EPS) and valuation.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and American CuMo Mining, as provided by MarketBeat.com.

Pharmerica (CNSX:PMC) and Argo Gold (CNSX:ARQ) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation and dividends.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for Pharmerica and Argo Gold, as provided by MarketBeat.com.

Profitability

This table compares Pharmerica and Argo Gold's net margins, return on equity and return on assets.

Earnings & Valuation

This table compares Pharmerica and Argo Gold's gross revenue, earnings per share (EPS) and valuation.